Home › Asset managers › Compare 2025-2026 › American Century vs Goldman Sachs
American Century 2025-2026 · Goldman Sachs 2025-2026 · Download the item list (CSV)
| Common items | Same | Differ | Split (not in %) | Same position | Fund-level | |
|---|---|---|---|---|---|---|
| All ballot items | 62,070 | 57,477 | 3,807 | 786 | 93.8% | 93.2% |
| Board proposals | 50,440 | 46,194 | 3,546 | 700 | 92.9% | 92.2% |
| E&S shareholder proposals | 176 | 171 | 5 | 0 | 97.2% | 97.2% |
| Other items | 11,454 | 11,112 | 256 | 86 | 97.7% | 97.4% |
Everything Voted differently Split votes
All ballot items Board proposals E&S shareholder proposals Other items
4,593 items. “Voted differently”: each manager’s funds all voted one way, and the two ways differ. “Split”: at least one manager’s funds did not all vote the same way.
| Company | Meeting | Proposal | On the ballot from | Board recommended | American Century | Goldman Sachs |
|---|---|---|---|---|---|---|
| COCA-COLA EUROPACIFIC PARTNERS | May 28, 2026 | RE-ELECT MANOLO ARROYO AS DIRECTOR Director Elections |
Board | For | AGAINST 4 funds |
FOR 12 funds |
| CODA OCTOPUS GROUP, INC. | September 10, 2025 | To vote, on an advisory basis, to approve the compensation of our named executive officers. Say-on-Pay |
Board | For | AGAINST 2 funds |
FOR 1 fund |
| COGENT BIOSCIENCES, INC. | June 9, 2026 | Approval, on a non-binding, advisory basis, of the compensation of the Company's named executive officers. Say-on-Pay |
Board | For | AGAINST 6 funds |
FOR 8 funds |
| COGENT COMMUNICATIONS HOLDINGS, INC. | May 1, 2026 | To approve the Third Amended and Restated 2017 Incentive Award Plan of the Company, including an increase in the number of shares available for issuance thereunder by 1.5 million shares. Compensation |
Board | For | AGAINST 2 funds |
FOR 2 funds |
| COGENT COMMUNICATIONS HOLDINGS, INC. | May 1, 2026 | To hold an advisory vote to approve named executive officer compensation. Compensation |
Board | For | AGAINST 3 funds |
FOR 2 funds |
| COHERENT CORP. | November 13, 2025 | Non-binding advisory vote to approve compensation paid to named executive officers in fiscal year 2025. Say-on-Pay |
Board | For | AGAINST 4 funds |
FOR 5 funds |
| COHERUS ONCOLOGY, INC. | May 29, 2026 | To approve an increase in the number of shares of our common stock reserved for issuance under the Amended and Restated 2014 Equity Incentive Award Plan. Compensation |
Board | For | AGAINST 1 fund |
FOR 3 funds |
| COHERUS ONCOLOGY, INC. | May 29, 2026 | To vote on a non-binding, advisory basis to approve the compensation of the Company's named executive officers (a "Say-on-Pay" vote). Say-on-Pay |
Board | For | AGAINST 2 funds |
FOR 4 funds |
| COHU, INC. | May 15, 2026 | Approve the Cohu, Inc. 2026 Equity Incentive Plan. Compensation |
Board | For | AGAINST 6 funds |
FOR 10 funds |
| COLLEGIUM PHARMACEUTICAL, INC. | May 14, 2026 | Approval of, on an advisory basis, the compensation of the Company's named executive officers Say-on-Pay |
Board | For | AGAINST 10 funds |
FOR 3 funds |
| COLONIAL SFL SOCIMI SA | June 17, 2026 | REELECT JUAN JOSE BRUGERA CLAVERO AS DIRECTOR Director Elections |
Board | For | AGAINST 1 fund |
FOR 1 fund |
| COLOPLAST A/S | December 4, 2025 | REELECT ANNETTE BRULS AS DIRECTOR Director Elections |
Board | For | FOR 3 funds |
ABSTAIN 5 funds |
| COLOPLAST A/S | December 4, 2025 | REELECT JETTE NYGAARD-ANDERSEN AS DIRECTOR Director Elections |
Board | For | FOR 3 funds |
ABSTAIN 5 funds |
| COLRUYT GROUP N.V. | September 24, 2025 | Reelect 7 Capital BV, Permanently Represented by Chantal De Vrieze, as Independent Director Director Elections |
Board | For | FOR 4 funds |
AGAINST 3 funds |
| COLRUYT GROUP N.V. | September 24, 2025 | Reelect Fast Forward Services BV, Permanently Represented by Rika Coppens, as Independent Director Director Elections |
Board | For | FOR 4 funds |
AGAINST 3 funds |
| COLRUYT GROUP N.V. | September 24, 2025 | Reelect Rudann BV, Permanently Represented by Rudi Peeters, as Independent Director Director Elections |
Board | For | FOR 4 funds |
AGAINST 3 funds |
| COLUMBIA SPORTSWEAR COMPANY | June 10, 2026 | To approve the Columbia Sportswear Company Amended and Restated 2020 Stock Incentive Plan. Compensation |
Board | For | AGAINST 8 funds |
FOR 3 funds |
| COMERICA INCORPORATED | January 6, 2026 | Proposal to approve, on an advisory (non-binding) basis, the merger-related compensation payments that will or may be paid to Comerica's named executive officers in connection with the first merger. Say-on-Pay |
Board | For | AGAINST 8 funds |
FOR 4 funds |
| COMMERCE.COM, INC. | May 14, 2026 | Non-binding advisory vote to approve the compensation of our named executive officers. Say-on-Pay |
Board | For | AGAINST 2 funds |
FOR 3 funds |
| COMMERCIAL METALS COMPANY | January 14, 2026 | The approval, on an advisory basis, of the compensation of our named executive officers Say-on-Pay |
Board | For | AGAINST 14 funds |
FOR 9 funds |
| COMMSCOPE HOLDING COMPANY, INC. | October 16, 2025 | A proposal to approve, on an advisory, non-binding basis, certain compensation that has, will or may be paid or become payable to the Company's named executive officers in connection with the CCS Sale Transaction (the ''Advisory Compensation Proposal''). Say-on-Pay |
Board | For | AGAINST 2 funds |
FOR 9 funds |
| COMMUNITY FINANCIAL SYSTEM, INC. | May 20, 2026 | Advisory vote on executive compensation. Say-on-Pay |
Board | For | FOR 7 funds |
AGAINST 4 funds |
| COMMUNITY HEALTH SYSTEMS, INC. | May 12, 2026 | Proposal to approve on an advisory (non-binding) basis the compensation of the Company's named executive officers. Say-on-Pay |
Board | For | FOR 1 fund |
AGAINST 7 funds |
| COMMUNITY WEST BANCSHARES | May 27, 2026 | To adopt a non-binding advisory resolution approving executive compensation. Say-on-Pay |
Board | For | FOR 7 funds |
AGAINST 2 funds |
| COMMVAULT SYSTEMS, INC. | August 7, 2025 | To approve additional shares to be available for grant under Commvault's 2016 Omnibus Incentive Plan. Compensation |
Board | For | AGAINST 6 funds |
FOR 11 funds |
| COMPAGNIE DES ALPES SA | March 11, 2026 | Reelect Anne Yannic as Director Director Elections |
Board | For | FOR 6 funds |
AGAINST 1 fund |
| COMPAGNIE FINANCIERE RICHEMONT SA | September 10, 2025 | REELECT ANTON RUPERT AS DIRECTOR Director Elections |
Board | Not determined | AGAINST 5 funds |
FOR 8 funds |
| COMPASS MINERALS INTERNATIONAL, INC. | March 5, 2026 | Approve, on an advisory basis, the compensation of our named executive officers. Say-on-Pay |
Board | For | AGAINST 10 funds |
FOR 3 funds |
| COMPASS THERAPEUTICS, INC. | June 10, 2026 | To approve, on a non-binding, advisory basis, the compensation of our named executive officers. Say-on-Pay |
Board | For | AGAINST 3 funds |
FOR 3 funds |
| COMPASS THERAPEUTICS, INC. | June 10, 2026 | To elect two class III directors to our Board of Directors, to serve until the 2029 annual meeting of stockholders and until his successor has been duly elected and qualified, or until his earlier death, resignation or removal. Thomas J. Schuetz, M.D., Ph.D. Director Elections |
Board | For | WITHHOLD 2 funds |
FOR 2 funds |
| COMPASS, INC. | May 14, 2026 | Advisory Vote to Approve 2025 Named Executive Officer Compensation ("Say-on-Pay Vote") Say-on-Pay |
Board | For | AGAINST 5 funds |
FOR 4 funds |
| CONFLUENT, INC. | February 12, 2026 | To approve, on a non-binding, advisory basis, the compensation that will or may become payable by Confluent, Inc. to its named executive officers in connection with the merger contemplated by the merger agreement. Say-on-Pay |
Board | For | AGAINST 3 funds |
FOR 8 funds |
| CONMED CORPORATION | May 18, 2026 | Advisory vote to approve named executive officer compensation. Say-on-Pay |
Board | For | AGAINST 5 funds |
FOR 3 funds |
| CONSENSUS CLOUD SOLUTIONS, INC. | June 10, 2026 | To approve, on an advisory, non-binding basis, the compensation of the Company's named executive officers. Say-on-Pay |
Board | For | AGAINST 4 funds |
FOR 6 funds |
| CONSTELLIUM SE | May 21, 2026 | Approval, on an advisory (non-binding) basis, of the 2025 compensation of the Company's named executive officers Say-on-Pay |
Board | For | AGAINST 8 funds |
FOR 10 funds |
| CONSTRUCCIONES Y AUXILIAR DE FERROCARRILES SA | June 13, 2026 | Reelect Andres Arizkorreta Garcia as Director Director Elections |
Board | For | AGAINST 10 funds |
FOR 1 fund |
| CONSTRUCTION PARTNERS INC | March 24, 2026 | Proposal to elect two Class II directors to serve for a three-year term expiring at the 2029 annual meeting of stockholders. Craig Jennings Director Elections |
Board | For | WITHHOLD 6 funds |
FOR 7 funds |
| CONSUMER PORTFOLIO SERVICES, INC. | November 19, 2025 | To approve an advisory resolution on named executive officer compensation. Say-on-Pay |
Board | For | AGAINST 6 funds |
FOR 3 funds |
| CONTANGO ORE, INC. | March 17, 2026 | The Incentive Plan Proposal - To approve the 2026 Omnibus Incentive Plan. Compensation |
Board | For | AGAINST 1 fund |
FOR 1 fund |
| CONTANGO ORE, INC. | March 17, 2026 | The Share Increase Proposal - To approve the increase of the number of authorized Contango Shares from 45,000,000 shares to 250,000,000 shares and the related amendment to the Certificate of Incorporation of Contango, as amended (the "Charter") that will be set forth in a Certificate of Amendment to the Charter. Capital Structure |
Board | For | AGAINST 1 fund |
FOR 1 fund |
| CONTINENTAL AG | April 30, 2026 | REELECT SABINE NEUSS TO THE SUPERVISORY BOARD Director Elections |
Board | For | AGAINST 8 funds |
FOR 5 funds |
| CONVATEC GROUP PLC | May 21, 2026 | Approve Remuneration Report Say-on-Pay |
Board | For | AGAINST 3 funds |
FOR 4 funds |
| CORBUS PHARMACEUTICALS HOLDINGS, INC. | May 13, 2026 | Approval of an amendment to the Corbus Pharmaceuticals Holdings, Inc. 2024 Equity Compensation Plan to increase the number of shares of common stock authorized for issuance thereunder by 3,000,000 shares to 5,000,000 shares. Compensation |
Board | For | AGAINST 1 fund |
FOR 1 fund |
| CORBUS PHARMACEUTICALS HOLDINGS, INC. | May 13, 2026 | Approval, on an advisory basis, of the executive compensation of the Company's named executive officers. Say-on-Pay |
Board | For | AGAINST 2 funds |
FOR 2 funds |
| CORCEPT THERAPEUTICS INCORPORATED | May 21, 2026 | To approve, on an advisory basis, the compensation of the company's named executive officers as disclosed in the accompanying proxy statement. Say-on-Pay |
Board | For | AGAINST 4 funds |
FOR 3 funds |
| CORE LABORATORIES INC. | May 12, 2026 | To approve, on an advisory basis, the compensation philosophy, policies and procedures described in the section entitled Compensation Discussion and Analysis ("CD&A"), and the compensation of the Company's named executive officers as disclosed pursuant to the U.S. Securities and Exchange Commission's compensation disclosure rules, including the compensation tables. Say-on-Pay |
Board | For | AGAINST 9 funds |
FOR 6 funds |
| CORE SCIENTIFIC, INC. | May 12, 2026 | To approve, on a non-binding, advisory basis, the compensation of our named executive officers. Say-on-Pay |
Board | For | AGAINST 2 funds |
FOR 8 funds |
| CORECARD CORPORATION | October 28, 2025 | Proposal to approve, on an advisory (non-binding) basis, the compensation that may be paid or become payable to CoreCard's named executive officers that is based on or otherwise relates to the Merger (the ''Advisory Compensation Proposal''). Say-on-Pay |
Board | For | AGAINST 6 funds |
FOR 3 funds |
| COREWEAVE, INC. | June 8, 2026 | Election of Class I Director: Michael Intrator Director Elections |
Board | For | WITHHOLD 2 funds |
FOR 4 funds |
| CORPAY, INC. | May 7, 2026 | Advisory vote to approve named executive officer compensation. Say-on-Pay |
Board | For | AGAINST 12 funds |
FOR 16 funds |
| CORPAY, INC. | May 7, 2026 | Elect Directors nominated by the Board of Directors for a one-year term: Annabelle Bexiga Director Elections |
Board | For | AGAINST 11 funds |
FOR 13 funds |
| CORPAY, INC. | May 7, 2026 | Elect Directors nominated by the Board of Directors for a one-year term: Hala G. Moddelmog Director Elections |
Board | For | AGAINST 11 funds |
FOR 13 funds |
| CORPAY, INC. | May 7, 2026 | Elect Directors nominated by the Board of Directors for a one-year term: Joseph W. Farrelly Director Elections |
Board | For | AGAINST 11 funds |
FOR 13 funds |
| CORPAY, INC. | May 7, 2026 | Elect Directors nominated by the Board of Directors for a one-year term: Steven T. Stull Director Elections |
Board | For | AGAINST 11 funds |
FOR 13 funds |
| CORPAY, INC. | May 7, 2026 | Elect Directors nominated by the Board of Directors for a one-year term: Thomas M. Hagerty Director Elections |
Board | For | AGAINST 11 funds |
FOR 13 funds |
| CORVEL CORPORATION | August 7, 2025 | To approve the 2025 Stock Incentive Plan. Compensation |
Board | For | AGAINST 6 funds |
FOR 6 funds |
| COSMO PHARMACEUTICALS N.V. | April 10, 2026 | AUTHORIZE BOARD TO EXCLUDE PREEMPTIVE RIGHTS FROM SHARE ISSUANCES UNDER THE AUTHORIZATIONS MENTIONED IN PROPOSAL 13 Capital Structure |
Board | For | FOR 5 funds |
AGAINST 1 fund |
| COSMO PHARMACEUTICALS N.V. | April 10, 2026 | REELECT ALESSANDRO DELLA CHA AS NON-EXECUTIVE DIRECTOR Director Elections |
Board | For | AGAINST 5 funds |
FOR 1 fund |
| COSMO PHARMACEUTICALS N.V. | April 10, 2026 | REELECT MAURO SEVERINO AJANI AS NON-EXECUTIVE DIRECTOR Director Elections |
Board | For | AGAINST 5 funds |
FOR 1 fund |
| COSTAR GROUP, INC. | June 23, 2026 | Proposal to approve, on an advisory basis, the Company's executive compensation. Say-on-Pay |
Board | For | AGAINST 6 funds |
FOR 11 funds |
| COUPANG, INC. | June 11, 2026 | To consider a non-binding vote to approve the compensation of Coupang, Inc.'s named executive officers. Say-on-Pay |
Board | For | AGAINST 13 funds |
FOR 6 funds |
| COUSINS PROPERTIES INCORPORATED | April 28, 2026 | Approve the Cousins Properties Incorporated Amended and Restated 2019 Omnibus Incentive Stock Plan. Compensation |
Board | For | AGAINST 1 fund |
FOR 5 funds |
| CPFL ENERGIA SA | April 29, 2026 | Approve Remuneration of Company's Management and Fiscal Council Compensation |
Board | For | AGAINST 4 funds |
FOR 1 fund |
| CPFL ENERGIA SA | April 29, 2026 | Ratify Peng Sun and Zhonghua Wei as Directors Director Elections |
Board | For | AGAINST 4 funds |
FOR 1 fund |
| CRA INTERNATIONAL, INC. | July 17, 2025 | To approve, on an advisory basis, the compensation paid to CRA's named executive officers, as disclosed in the proxy statement for the 2025 meeting of its shareholders. Say-on-Pay |
Board | For | AGAINST 7 funds |
FOR 5 funds |
| CREDIT AGRICOLE SA | May 20, 2026 | Elect Marc Didier as Director Director Elections |
Board | For | AGAINST 5 funds |
FOR 4 funds |
| CREDIT AGRICOLE SA | May 20, 2026 | Elect Richard Laborie as Director Following Resignation of Nicole Gourmelon Director Elections |
Board | For | AGAINST 5 funds |
FOR 4 funds |
| CREDIT AGRICOLE SA | May 20, 2026 | Ratify Appointment of Franck Alexandre as Director Following Resignation of Dominique Lefebvre Director Elections |
Board | For | AGAINST 5 funds |
FOR 4 funds |
| CREDIT AGRICOLE SA | May 20, 2026 | Reelect Alessia Mosca as Director Director Elections |
Board | For | FOR 5 funds |
AGAINST 4 funds |
| CREDIT AGRICOLE SA | May 20, 2026 | Reelect Pascal Lheureux as Director Director Elections |
Board | For | AGAINST 5 funds |
FOR 4 funds |
| CREDO TECHNOLOGY GROUP HOLDING LIMITED | October 13, 2025 | To approve, on a non-binding advisory basis, the compensation of the Company's named executive officers, as disclosed in the proxy statement. Say-on-Pay |
Board | For | AGAINST 8 funds |
FOR 9 funds |
| CREXENDO INC | December 2, 2025 | To consider and vote upon a proposal for advisory approval of the compensation of the Company's named executive officers; Say-on-Pay |
Board | For | AGAINST 2 funds |
FOR 3 funds |
| CRICUT, INC. | June 3, 2026 | To approve, by non-binding vote, named executive officer compensation. Say-on-Pay |
Board | For | AGAINST 6 funds |
FOR 2 funds |
| CRINETICS PHARMACEUTICALS, INC. | June 18, 2026 | To approve, on an advisory basis, the compensation of the Company's named executive officers as disclosed in the proxy statement pursuant to the compensation disclosure rules of the Securities and Exchange Commission; Say-on-Pay |
Board | For | AGAINST 8 funds |
FOR 6 funds |
| CRISPR THERAPEUTICS AG | June 4, 2026 | Approval of the CRISPR Therapeutics AG 2026 Stock Option and Incentive Plan. Compensation |
Board | For | AGAINST 5 funds |
FOR 3 funds |
| CRISPR THERAPEUTICS AG | June 4, 2026 | Binding vote on maximum equity for members of the Board of Directors from the 2026 Annual General Meeting to the 2027 annual general meeting of shareholders. Compensation |
Board | For | AGAINST 5 funds |
FOR 3 funds |
| CRISPR THERAPEUTICS AG | June 4, 2026 | Binding vote on maximum equity for members of the Executive Committee from the 2026 Annual General Meeting to the 2027 annual general meeting of shareholders. Compensation |
Board | For | AGAINST 5 funds |
FOR 3 funds |
| CRISPR THERAPEUTICS AG | June 4, 2026 | Binding vote on maximum non- performance-related compensation for members of the Board of Directors from the 2026 Annual General Meeting to the 2027 annual general meeting of shareholders. Compensation |
Board | For | AGAINST 5 funds |
FOR 3 funds |
| CRISPR THERAPEUTICS AG | June 4, 2026 | Binding vote on maximum variable compensation for members of the Executive Committee for the current year ending December 31, 2026. Compensation |
Board | For | AGAINST 5 funds |
FOR 3 funds |
| CROWN CASTLE INC. | May 20, 2026 | The non-binding, advisory vote to approve the compensation of the Company's named executive officers. Say-on-Pay |
Board | For | AGAINST 2 funds |
FOR 10 funds |
| CRYOPORT, INC. | June 5, 2026 | To approve an amendment to the Cryoport, Inc. 2018 Omnibus Equity Incentive Plan to increase the number of authorized shares for issuance thereunder from 10,350,000 to 14,625,000; Compensation |
Board | For | AGAINST 4 funds |
FOR 2 funds |
| CRYOPORT, INC. | June 5, 2026 | To approve, on an advisory basis, the compensation of the named executive officers, as disclosed in the Proxy Statement; Say-on-Pay |
Board | For | AGAINST 5 funds |
FOR 3 funds |
| CSG SYSTEMS INTERNATIONAL, INC. | January 30, 2026 | To approve, on a non-binding, advisory basis, the compensation that may be paid or become payable to the named executive officers of CSG in connection with the consummation of the merger; and Say-on-Pay |
Board | For | AGAINST 6 funds |
FOR 3 funds |
| CSPC PHARMACEUTICAL GROUP LIMITED | May 28, 2026 | Elect Law Cheuk Kin Stephen as Director Director Elections |
Board | For | FOR 4 funds |
AGAINST 2 funds |
| CTP N.V. | May 20, 2026 | AUTHORIZE BOARD TO EXCLUDE PREEMPTIVE RIGHTS FROM SHARE ISSUANCES Capital Structure |
Board | For | FOR 4 funds |
AGAINST 2 funds |
| CTP N.V. | May 20, 2026 | GRANT BOARD AUTHORITY TO ISSUE SHARES Capital Structure |
Board | For | AGAINST 4 funds |
FOR 2 funds |
| CULLINAN THERAPEUTICS, INC. | June 16, 2026 | Proposal to vote, on an advisory basis, to approve our named executive officer compensation. Say-on-Pay |
Board | For | AGAINST 5 funds |
FOR 4 funds |
| CURIOSITYSTREAM INC. | May 20, 2026 | To approve, on an advisory basis, the compensation paid to the Company's named executive officers as disclosed in the Proxy Statement. Compensation |
Board | For | AGAINST 2 funds |
FOR 6 funds |
| CUSHMAN & WAKEFIELD LTD. | May 14, 2026 | Approval of our 2026 Omnibus Share and Cash Incentive Plan. Compensation |
Board | For | AGAINST 5 funds |
FOR 1 fund |
| CVB FINANCIAL CORP. | May 20, 2026 | To approve, on a non-binding advisory basis, the compensation of CVB Financial Corp.'s named executive officers ("Say-on-Pay"). Say-on-Pay |
Board | For | FOR 9 funds |
AGAINST 3 funds |
| CVR ENERGY, INC. | June 4, 2026 | To approve, on an advisory basis, our named executive officer compensation. Say-on-Pay |
Board | For | AGAINST 7 funds |
FOR 1 fund |
| CVRx, Inc. | June 1, 2026 | Election of Class II Directors: Joseph Slattery Director Elections |
Board | For | WITHHOLD 1 fund |
FOR 4 funds |
| CVRx, Inc. | June 1, 2026 | Election of Class II Directors: Kevin Hykes Director Elections |
Board | For | WITHHOLD 1 fund |
FOR 4 funds |
| CYTEK BIOSCIENCES, INC. | June 10, 2026 | To approve, on a non-binding, advisory basis, the compensation of our named executive officers for the year ended December 31, 2025, as set forth in our proxy statement. Say-on-Pay |
Board | For | AGAINST 6 funds |
FOR 8 funds |
| Caixa Seguridade Participacoes SA | April 28, 2026 | Ratify Luiz Francisco Monteiro De Barros Neto as Director Director Elections |
Board | For | AGAINST 4 funds |
FOR 1 fund |
| Camping World Holdings, Inc. | May 21, 2026 | Election of Class I Directors: K. Dillon Schickli Director Elections |
Board | For | WITHHOLD 1 fund |
FOR 4 funds |
| Canara Bank | June 23, 2026 | Approve Appointment of Sunil Kumar Chugh as Executive Director Compensation |
Board | For | AGAINST 5 funds |
FOR 3 funds |
| Candel Therapeutics, Inc. | June 23, 2026 | Election of Class II Directors: Edward J. Benz, Jr. Director Elections |
Board | For | WITHHOLD 1 fund |
FOR 4 funds |
| Capcom Co., Ltd. | June 18, 2026 | Approve Allocation of Income, with a Final Dividend of JPY 25 Capital Structure |
Board | For | FOR 4 funds |
AGAINST 3 funds |
| Capitol Federal Financial, Inc. | January 27, 2026 | Election of Directors: (for three-year terms): Jeffrey M. Johnson Director Elections |
Board | For | FOR 6 funds |
AGAINST 5 funds |
← Previous Page 10 of 46 Next →
How items are matched and positions counted: see the comparison table and the methodology. Built October 25, 2026 from SEC Form N-PX filings.